| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drosophila Proteins | 27 | 2016 | 488 | 5.220 |
Why?
|
| Retinoblastoma Protein | 14 | 2013 | 66 | 2.570 |
Why?
|
| Drosophila melanogaster | 14 | 2016 | 599 | 2.470 |
Why?
|
| Drosophila | 19 | 2017 | 498 | 2.330 |
Why?
|
| Gene Expression Regulation, Developmental | 15 | 2015 | 623 | 2.310 |
Why?
|
| Apoptosis | 24 | 2016 | 1683 | 2.300 |
Why?
|
| Cell Cycle Proteins | 13 | 2013 | 388 | 1.970 |
Why?
|
| Genes, Retinoblastoma | 5 | 2014 | 22 | 1.930 |
Why?
|
| DNA-Binding Proteins | 16 | 2014 | 1208 | 1.850 |
Why?
|
| Transcription Factors | 20 | 2013 | 1565 | 1.750 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2015 | 165 | 1.550 |
Why?
|
| Eye | 10 | 2011 | 111 | 1.440 |
Why?
|
| ErbB Receptors | 4 | 2016 | 485 | 1.440 |
Why?
|
| Cell Differentiation | 12 | 2015 | 1458 | 1.300 |
Why?
|
| Photoreceptor Cells, Invertebrate | 5 | 2015 | 21 | 1.200 |
Why?
|
| G1 Phase | 7 | 2013 | 63 | 1.160 |
Why?
|
| Signal Transduction | 13 | 2016 | 3241 | 1.150 |
Why?
|
| Trans-Activators | 7 | 2016 | 429 | 1.050 |
Why?
|
| Nuclear Proteins | 5 | 2016 | 696 | 1.030 |
Why?
|
| Cell Death | 6 | 2013 | 256 | 1.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 9 | 2016 | 276 | 0.980 |
Why?
|
| Panax | 9 | 2016 | 170 | 0.950 |
Why?
|
| Cyclins | 7 | 2008 | 82 | 0.930 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2014 | 83 | 0.890 |
Why?
|
| Nerve Tissue Proteins | 3 | 2014 | 503 | 0.880 |
Why?
|
| Cell Cycle | 14 | 2014 | 502 | 0.860 |
Why?
|
| Ginsenosides | 8 | 2016 | 123 | 0.840 |
Why?
|
| Animals | 51 | 2017 | 26582 | 0.830 |
Why?
|
| Mitosis | 4 | 2008 | 153 | 0.830 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2014 | 645 | 0.820 |
Why?
|
| Membrane Proteins | 5 | 2016 | 1196 | 0.810 |
Why?
|
| Plant Extracts | 10 | 2014 | 244 | 0.780 |
Why?
|
| Cyclin E | 5 | 2010 | 27 | 0.760 |
Why?
|
| Retina | 2 | 2014 | 213 | 0.710 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2016 | 67 | 0.670 |
Why?
|
| Mutation | 14 | 2016 | 3968 | 0.640 |
Why?
|
| Retinoblastoma | 2 | 2009 | 28 | 0.640 |
Why?
|
| Repressor Proteins | 4 | 2015 | 403 | 0.620 |
Why?
|
| Phytotherapy | 6 | 2016 | 133 | 0.620 |
Why?
|
| Wnt Proteins | 2 | 2017 | 123 | 0.610 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 13 | 0.580 |
Why?
|
| Colorectal Neoplasms | 14 | 2014 | 938 | 0.580 |
Why?
|
| Receptors, Invertebrate Peptide | 1 | 2016 | 3 | 0.570 |
Why?
|
| Cell Survival | 4 | 2016 | 969 | 0.570 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2016 | 15 | 0.560 |
Why?
|
| S Phase | 4 | 2013 | 62 | 0.560 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2016 | 379 | 0.560 |
Why?
|
| Diynes | 2 | 2013 | 7 | 0.560 |
Why?
|
| Fatty Alcohols | 2 | 2013 | 10 | 0.560 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 49 | 0.550 |
Why?
|
| Carrier Proteins | 6 | 2001 | 673 | 0.550 |
Why?
|
| Cell Proliferation | 13 | 2016 | 1578 | 0.550 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2014 | 199 | 0.540 |
Why?
|
| Phosphoproteins | 1 | 2016 | 254 | 0.510 |
Why?
|
| Enhancer Elements, Genetic | 7 | 2014 | 266 | 0.500 |
Why?
|
| Animals, Genetically Modified | 7 | 2014 | 181 | 0.500 |
Why?
|
| Retinal Neurons | 1 | 2014 | 10 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 302 | 0.490 |
Why?
|
| Wings, Animal | 3 | 2016 | 95 | 0.480 |
Why?
|
| Cell Line, Tumor | 13 | 2014 | 2426 | 0.470 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 95 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 189 | 0.450 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 182 | 0.440 |
Why?
|
| Genes, Insect | 3 | 2008 | 183 | 0.420 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2013 | 381 | 0.420 |
Why?
|
| Transcription, Genetic | 8 | 2017 | 1135 | 0.400 |
Why?
|
| Stress, Physiological | 1 | 2013 | 227 | 0.390 |
Why?
|
| Wnt1 Protein | 2 | 2008 | 24 | 0.390 |
Why?
|
| Cell Lineage | 2 | 2015 | 273 | 0.390 |
Why?
|
| Neoplasms | 4 | 2016 | 2898 | 0.390 |
Why?
|
| Energy Metabolism | 1 | 2013 | 271 | 0.390 |
Why?
|
| E2F Transcription Factors | 9 | 2008 | 19 | 0.390 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 279 | 0.380 |
Why?
|
| HCT116 Cells | 9 | 2014 | 151 | 0.370 |
Why?
|
| Phenotype | 10 | 2015 | 2378 | 0.370 |
Why?
|
| Cyclin-Dependent Kinases | 4 | 2004 | 43 | 0.360 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 193 | 0.360 |
Why?
|
| E2F1 Transcription Factor | 1 | 2009 | 13 | 0.360 |
Why?
|
| Models, Molecular | 1 | 2014 | 1286 | 0.360 |
Why?
|
| Gene Silencing | 1 | 2010 | 172 | 0.350 |
Why?
|
| Retinal Neoplasms | 1 | 2009 | 10 | 0.350 |
Why?
|
| Genes, Lethal | 4 | 2014 | 53 | 0.350 |
Why?
|
| Binding Sites | 6 | 2014 | 1098 | 0.340 |
Why?
|
| Panax notoginseng | 3 | 2016 | 23 | 0.340 |
Why?
|
| Protein Kinases | 2 | 2013 | 209 | 0.330 |
Why?
|
| Peripheral Nervous System | 1 | 2008 | 21 | 0.330 |
Why?
|
| Neoplasms, Experimental | 1 | 2010 | 269 | 0.330 |
Why?
|
| Antioxidants | 1 | 2009 | 223 | 0.320 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 78 | 0.320 |
Why?
|
| Compound Eye, Arthropod | 1 | 2007 | 7 | 0.310 |
Why?
|
| Organogenesis | 1 | 2007 | 41 | 0.310 |
Why?
|
| Base Sequence | 8 | 2014 | 2330 | 0.300 |
Why?
|
| Eye Neoplasms | 1 | 2006 | 27 | 0.290 |
Why?
|
| Medulloblastoma | 1 | 2006 | 36 | 0.290 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 3030 | 0.280 |
Why?
|
| Cerebellar Neoplasms | 1 | 2006 | 36 | 0.280 |
Why?
|
| NF-kappa B | 4 | 2013 | 444 | 0.280 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 1994 | 66 | 0.280 |
Why?
|
| High Mobility Group Proteins | 3 | 1994 | 26 | 0.270 |
Why?
|
| Reactive Oxygen Species | 4 | 2014 | 480 | 0.270 |
Why?
|
| Cell Nucleus | 3 | 2004 | 579 | 0.270 |
Why?
|
| Imaginal Discs | 2 | 2016 | 11 | 0.270 |
Why?
|
| Drug Synergism | 5 | 2012 | 303 | 0.270 |
Why?
|
| Up-Regulation | 4 | 2017 | 712 | 0.270 |
Why?
|
| Precancerous Conditions | 1 | 2006 | 196 | 0.260 |
Why?
|
| Cerebellum | 1 | 2006 | 247 | 0.250 |
Why?
|
| Interferon-beta | 4 | 1994 | 125 | 0.250 |
Why?
|
| DNA Primers | 3 | 2014 | 543 | 0.240 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 2360 | 0.240 |
Why?
|
| Sapogenins | 2 | 2014 | 24 | 0.240 |
Why?
|
| Oplopanax | 2 | 2014 | 29 | 0.240 |
Why?
|
| Mice | 14 | 2014 | 11352 | 0.240 |
Why?
|
| Cytoplasm | 1 | 2004 | 281 | 0.230 |
Why?
|
| Genes, Reporter | 3 | 2008 | 268 | 0.230 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 1753 | 0.230 |
Why?
|
| Homeodomain Proteins | 3 | 2014 | 536 | 0.230 |
Why?
|
| DNA Damage | 2 | 2003 | 366 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 4 | 2002 | 937 | 0.220 |
Why?
|
| Green Fluorescent Proteins | 3 | 2008 | 305 | 0.220 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 1993 | 90 | 0.210 |
Why?
|
| Hedgehog Proteins | 3 | 2010 | 93 | 0.210 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1920 | 0.200 |
Why?
|
| Caspases | 2 | 2012 | 155 | 0.200 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 2062 | 0.190 |
Why?
|
| Cyclin D | 4 | 2006 | 14 | 0.190 |
Why?
|
| Fruit | 3 | 2009 | 75 | 0.190 |
Why?
|
| Drugs, Chinese Herbal | 3 | 2010 | 67 | 0.190 |
Why?
|
| Eye Proteins | 2 | 2014 | 128 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 736 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2014 | 458 | 0.180 |
Why?
|
| Humans | 29 | 2016 | 86645 | 0.180 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 6 | 2001 | 10 | 0.180 |
Why?
|
| Anticarcinogenic Agents | 2 | 2013 | 70 | 0.180 |
Why?
|
| Models, Biological | 4 | 2015 | 1749 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2012 | 1197 | 0.180 |
Why?
|
| Mice, Nude | 4 | 2014 | 790 | 0.180 |
Why?
|
| Blotting, Western | 3 | 2010 | 782 | 0.170 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 1994 | 148 | 0.170 |
Why?
|
| Protein Binding | 3 | 2015 | 1456 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2009 | 315 | 0.160 |
Why?
|
| Boronic Acids | 1 | 2017 | 55 | 0.150 |
Why?
|
| Cell Division | 4 | 2002 | 696 | 0.150 |
Why?
|
| Enzyme Activation | 2 | 2011 | 692 | 0.150 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2003 | 135 | 0.150 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2016 | 3 | 0.140 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2016 | 5 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 91 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 236 | 0.140 |
Why?
|
| Adipocytes | 1 | 2017 | 155 | 0.140 |
Why?
|
| Gene Dosage | 2 | 2009 | 207 | 0.140 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 119 | 0.140 |
Why?
|
| Endosomes | 1 | 2016 | 75 | 0.140 |
Why?
|
| Autoantigens | 1 | 2016 | 127 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 2016 | 153 | 0.130 |
Why?
|
| PAX6 Transcription Factor | 1 | 2014 | 10 | 0.130 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 25 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2015 | 74 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2004 | 28 | 0.130 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 50 | 0.130 |
Why?
|
| Ubiquitinated Proteins | 1 | 2014 | 4 | 0.120 |
Why?
|
| Vacuoles | 2 | 2013 | 46 | 0.120 |
Why?
|
| Pyridoxaminephosphate Oxidase | 1 | 2014 | 3 | 0.120 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2014 | 22 | 0.120 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 29 | 0.120 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2014 | 35 | 0.120 |
Why?
|
| Dimerization | 1 | 2014 | 143 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 133 | 0.120 |
Why?
|
| Peptides | 1 | 2017 | 639 | 0.120 |
Why?
|
| Genistein | 1 | 2013 | 16 | 0.120 |
Why?
|
| Fluorouracil | 2 | 2012 | 556 | 0.110 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2013 | 52 | 0.110 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 286 | 0.110 |
Why?
|
| Sequence Deletion | 2 | 2008 | 205 | 0.110 |
Why?
|
| Checkpoint Kinase 2 | 2 | 2003 | 23 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 425 | 0.110 |
Why?
|
| Larva | 2 | 2011 | 118 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2012 | 67 | 0.110 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 39 | 0.110 |
Why?
|
| Autophagy | 1 | 2014 | 149 | 0.110 |
Why?
|
| Catechin | 1 | 2012 | 19 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 157 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 927 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 128 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 179 | 0.100 |
Why?
|
| Viruses | 1 | 1992 | 78 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 1961 | 0.100 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2010 | 25 | 0.100 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 363 | 0.100 |
Why?
|
| Camptothecin | 1 | 2012 | 189 | 0.100 |
Why?
|
| Caspase Inhibitors | 1 | 2010 | 33 | 0.100 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 146 | 0.100 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2010 | 53 | 0.100 |
Why?
|
| Cyclin A | 2 | 2007 | 28 | 0.100 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 59 | 0.100 |
Why?
|
| Veratrum Alkaloids | 2 | 2010 | 9 | 0.100 |
Why?
|
| Colitis | 1 | 2013 | 239 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2007 | 1981 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 222 | 0.090 |
Why?
|
| Acetylcysteine | 1 | 2010 | 69 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2010 | 83 | 0.090 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2010 | 99 | 0.090 |
Why?
|
| DNA Replication | 2 | 2001 | 164 | 0.090 |
Why?
|
| Alleles | 2 | 2014 | 1128 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2010 | 231 | 0.090 |
Why?
|
| Crosses, Genetic | 2 | 2014 | 171 | 0.090 |
Why?
|
| In Situ Hybridization | 2 | 2000 | 307 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2010 | 615 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 556 | 0.080 |
Why?
|
| Courtship | 1 | 2008 | 7 | 0.080 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 23 | 0.080 |
Why?
|
| Plant Roots | 4 | 2009 | 106 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2008 | 25 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 68 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 178 | 0.080 |
Why?
|
| Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2007 | 1 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2008 | 94 | 0.080 |
Why?
|
| Clone Cells | 1 | 2008 | 213 | 0.080 |
Why?
|
| Sexual Behavior, Animal | 1 | 2008 | 92 | 0.080 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 45 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2008 | 210 | 0.080 |
Why?
|
| Female | 8 | 2014 | 44534 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 46 | 0.080 |
Why?
|
| Sense Organs | 1 | 2007 | 6 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 2903 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2010 | 447 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 1384 | 0.070 |
Why?
|
| Patched Receptors | 1 | 2006 | 3 | 0.070 |
Why?
|
| Patched-1 Receptor | 1 | 2006 | 3 | 0.070 |
Why?
|
| Cyclin D2 | 1 | 2006 | 19 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 229 | 0.070 |
Why?
|
| Activating Transcription Factor 2 | 3 | 1994 | 5 | 0.070 |
Why?
|
| Purkinje Cells | 1 | 2006 | 80 | 0.070 |
Why?
|
| Extremities | 1 | 2007 | 167 | 0.070 |
Why?
|
| Multigene Family | 1 | 2006 | 202 | 0.070 |
Why?
|
| Expressed Sequence Tags | 1 | 2005 | 35 | 0.070 |
Why?
|
| Deoxycytidine | 1 | 2006 | 237 | 0.060 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2004 | 13 | 0.060 |
Why?
|
| cdc25 Phosphatases | 1 | 2004 | 18 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2010 | 1106 | 0.060 |
Why?
|
| Stem Cells | 1 | 2007 | 351 | 0.060 |
Why?
|
| Mammals | 1 | 2006 | 227 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 853 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2006 | 460 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2008 | 534 | 0.060 |
Why?
|
| Cisplatin | 1 | 2006 | 612 | 0.060 |
Why?
|
| Neurons | 2 | 2006 | 1546 | 0.060 |
Why?
|
| Gamma Rays | 1 | 2003 | 72 | 0.060 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2013 | 63 | 0.060 |
Why?
|
| Fertility | 1 | 2003 | 115 | 0.060 |
Why?
|
| Infertility, Female | 1 | 2003 | 93 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 57 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 2232 | 0.050 |
Why?
|
| Insect Proteins | 1 | 2002 | 88 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2001 | 111 | 0.050 |
Why?
|
| Transfection | 2 | 1993 | 896 | 0.050 |
Why?
|
| Biological Evolution | 1 | 2008 | 919 | 0.050 |
Why?
|
| Male | 5 | 2014 | 40967 | 0.050 |
Why?
|
| DNA | 4 | 2007 | 1294 | 0.050 |
Why?
|
| Suppression, Genetic | 1 | 2000 | 30 | 0.050 |
Why?
|
| Transcription Factor DP1 | 2 | 1996 | 5 | 0.050 |
Why?
|
| HT29 Cells | 2 | 2009 | 49 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 2438 | 0.040 |
Why?
|
| Macromolecular Substances | 2 | 2001 | 177 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 280 | 0.040 |
Why?
|
| Embryonic Development | 1 | 1999 | 74 | 0.040 |
Why?
|
| Gene Regulatory Networks | 2 | 2013 | 296 | 0.040 |
Why?
|
| HMGA1a Protein | 2 | 1994 | 3 | 0.040 |
Why?
|
| Child | 1 | 2009 | 6928 | 0.040 |
Why?
|
| Axin Protein | 1 | 2017 | 4 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1999 | 329 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 1074 | 0.040 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 1996 | 33 | 0.040 |
Why?
|
| beta Catenin | 1 | 2017 | 251 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1996 | 393 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 416 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 1994 | 10 | 0.030 |
Why?
|
| Gene Expression | 2 | 1996 | 1284 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1994 | 56 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 408 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1996 | 300 | 0.030 |
Why?
|
| Pyridoxine | 1 | 2014 | 3 | 0.030 |
Why?
|
| Vitamin B 6 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Pyridoxal Phosphate | 1 | 2014 | 13 | 0.030 |
Why?
|
| Sucrose | 1 | 2014 | 64 | 0.030 |
Why?
|
| Chromosomes | 1 | 2014 | 96 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2014 | 53 | 0.030 |
Why?
|
| Models, Structural | 1 | 1993 | 58 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2013 | 68 | 0.030 |
Why?
|
| Meiosis | 1 | 2014 | 80 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 646 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 86 | 0.030 |
Why?
|
| Saponins | 1 | 2013 | 41 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2013 | 82 | 0.030 |
Why?
|
| Isoflavones | 1 | 2013 | 13 | 0.030 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2013 | 11 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 100 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 169 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 311 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 351 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 54 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 26 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 989 | 0.030 |
Why?
|
| Heterografts | 1 | 2013 | 98 | 0.030 |
Why?
|
| Plasmids | 1 | 1993 | 287 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 1014 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2013 | 91 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2012 | 20 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 526 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 28 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2012 | 48 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2012 | 46 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 126 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2014 | 439 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2012 | 159 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 279 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2010 | 2 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1992 | 498 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 310 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2010 | 61 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2010 | 69 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 148 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 496 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 93 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2009 | 41 | 0.020 |
Why?
|
| Rhizome | 1 | 2009 | 6 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 369 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 535 | 0.020 |
Why?
|
| Flowers | 1 | 2009 | 36 | 0.020 |
Why?
|
| Heating | 1 | 2008 | 14 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2009 | 206 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2008 | 15 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 557 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 369 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 1047 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 679 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 879 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2006 | 121 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 689 | 0.020 |
Why?
|
| Genomic Library | 1 | 2005 | 33 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2818 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 3092 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2705 | 0.010 |
Why?
|
| Origin Recognition Complex | 1 | 2001 | 1 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 108 | 0.010 |
Why?
|
| Ovarian Follicle | 1 | 2001 | 72 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 645 | 0.010 |
Why?
|
| Chromatin | 1 | 2001 | 380 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 5210 | 0.010 |
Why?
|
| United States | 1 | 2008 | 6674 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1993 | 97 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1993 | 926 | 0.000 |
Why?
|